2004•Drug Metabolism and DispositionRequires access

EFFECT OF RECOMBINANT INTERLEUKIN-2 PRETREATMENT ON ORAL AND INTRAVENOUS DIGOXIN PHARMACOKINETICS AND P-GLYCOPROTEIN ACTIVITY IN MICE

Vincent Castagné, Laurence Bonhomme‐Faivre, Saı̈k Urien, Makram Ben Reguiga, Mireille Soursac, François Gimenez, Robert Farinotti

Open publisher page 19 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 19 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Digoxin, Pharmacokinetics, Pharmacology, Bioavailability, Oral administration, Drug interaction, P-glycoprotein, Chemistry

Back to paper search Browse research topics Original source

EFFECT OF RECOMBINANT INTERLEUKIN-2 PRETREATMENT ON ORAL AND INTRAVENOUS DIGOXIN PHARMACOKINETICS AND P-GLYCOPROTEIN ACTIVITY IN MICE — Research Paper | ScholarLens